<p>The Center for Cancer Research (CCR), of the intramural NCI undertook a multidimensional clinical genomics study of children and adolescent young adults with relapsed and refractory cancers who were enrolled on other therapeutic trials to determine the feasibility of a genome guided precision therapy protocol in these patients.</p><p>Note: NCIPM001blood - This sample was previously submitted with study <a href="https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs002207">phs002207</a>, with sample ID NCIPM001blood_E and SRR ID SRR18544311.</p>

Modelling Multi-Dimensional ClinOmics for Precision Therapy of Children    and Adolescent Young Adults with Relapsed and Refractory Cancer: A    Report from the Center for Cancer Research

Modelling Multi-Dimensional ClinOmics for Precision Therapy of Children and Adolescent Young Adults with Relapsed and Refractory Cancer: A Report from the Center for Cancer Research

Comprehensive genomic analysis of rhabdomyosarcoma reveals a landscape of alterations affecting a common genetic axis in fusion-positive and fusion-negative tumors.

The Genomic Landscape of the Ewing Sarcoma Family of Tumors Reveals Recurrent STAG2 Mutation

MultiDimensional ClinOmics for Precision Therapy of Children and Adolescent Young Adults with Relapsed and Refractory Cancer: A Report from the Center for Cancer Research

Immuno-transcriptomic profiling of extracranial pediatric solid malignancies